Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07569172

Improved Child Nutrition and Development Through Social Transfers

The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are:

* Does the social transfer increase complementary breastfeeding rates at 24-months postpartum? * Does the social transfer increase complementary breastfeeding duration? * Does the social transfer impact child health and development? * Does the social transfer impact maternal physical and mental health?

Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding.

Participants will:

Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Breastfeeding Allergies Anemia Antibiotic Use Behavior Blood Pressure Body Weight Body Weight Changes Breast Feeding Breastfeeding Continuation Breastfeeding Duration Breastfeeding Education Child Development Child Growth Communicable Diseases Cough Coughing Dermatitis Diarrhea Disease Attributes Eczema Feeding Behavior Hematologic Diseases Hemic and Lymphatic Diseases Hypersensitivity Immune System Diseases Infections Infectious Diseases Mental Health Pathologic Processes Pathological Conditions, Signs and Symptoms Personal Satisfaction Psychological Well-Being Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Digestive Signs and Symptoms, Respiratory Skin Diseases Skin Diseases, Eczematous Skin and Connective Tissue Diseases Stress Weight Loss

Age range

12 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are enrolled in the Taabo multigenerational birth cohort (MGC)
  • Completed the postpartum interview of the Taabo MGC
  • Have a child who is within two weeks of their 12-month birthday,
  • are breastfeeding at time of recruitment,
  • live in the Taabo HDSS, Côte d'Ivoire
  • have no illnesses that contraindicates breastfeeding,
  • had a healthy singleton infant with a birth weight of at least 2500 grams, and
  • agree to participate and sign an informed consent; if underage (12-17 years), a legal representative will also have to agree to sign the informed consent

Exclusion criteria

  • Plans to move permanently outside study area
  • Has a medical, intellectual or psychological disability
  • Contraindication for breastfeeding
  • Children born with < 2500 grams

Treatment and study plan

Social Transfer

Other

A social transfer will be given conditioned upon breastfeeding at 24-months postpartum.

Primary outcomes

  1. Prevalence of Complementary Breastfeeding

    Time frame: from 12 to 24 months postpartum

    Prevalence of complementary breastfeeding at 24 months postpartum.

  2. Complementary Breastfeeding Duration

    Time frame: from 12 to 24 months postpartum

    Duration of complementary breastfeeding in weeks.

Secondary outcomes

  1. Weight-for-Age z-score

    Time frame: 12 months; 24 months

    Infants will be weighed in kilograms by a mobile weighing scale. Measurements will be analyzed as age standardized z-scores.

  2. Child Health Outcomes

    Time frame: 12 months; 24 months

    We will assess the child's health outcomes by using a questionnaire administered to the caregiver. The questionnaire will ask a range of yes or no questions about child diarrhea, respiratory illness, fever, and child antibiotic use.

  3. Percent weight loss

    Time frame: 12 months; 24 months;

    Percent weight loss will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Percent weight loss will be calculated as ((current weight - pregnancy weight) / pregnancy weight) × 100.

  4. Mother and Child Hemoglobin Levels

    Time frame: 12 months; 24 months

    We will assess the mother and child anemia levels. The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Iron levels will be analyzed as a continuous outcome.

  5. Maternal Depression

    Time frame: 12 months; 24 months

    Maternal postpartum depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9); categorized as a binary: no depression (score <10) or depression present (score ≥10).

  6. Height-for-age z-score

    Time frame: 12 months; 24 months

    Height will be measured in centimeters by using a Height Measuring Device, stadiometer, 20-205cm. All measurements will be analyzed as age standardized z-scores

  7. Mid-upper arm circumference (MUAC)

    Time frame: 12 months; 24 months

    Infants will be measured for mid-upper arm circumference (MUAC) using non-stretchable measuring tape. All measurements will be analyzed as age standardized z-scores.

  8. Mother and Child Anemia

    Time frame: 12 months; 24 months

    The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Hemoglobin levels (gm/dL) will be used to categorize mothers and children into a binary variable: anemic or not anemic.

  9. Maternal weight change

    Time frame: 12 months; 24 months;

    Weight weight change will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Maternal weight change will be calculated as the difference between postpartum weight and pregnancy weight. Because pregnancy weight varies by gestational age, analyses will control for gestational age at pregnancy weight measurement and time postpartum at outcome measurement.

    Categorized as: no weight loss (0 kg); moderate weight loss (<0 to >-5 kg); high weight loss (≥-5 kg); moderate weight gain (>0 to <5 kg); high weight gain (≥5 kg).

  10. Change in systolic and diastolic blood pressure (mmHg)

    Time frame: 12 months; 24 months;

    Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be categorized as low, normal, or high according to standard clinical thresholds.

  11. Change in systolic and diastolic blood pressure (mmHg)

    Time frame: 12 months; 24 months;

    Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be analyzed as a continuous measure.

  12. Caregiver Reported Early Development Instruments (CREDI) cognitive z-score

    Time frame: 12 months; 24 months

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.

  13. CREDI language z-score

    Time frame: 12 months; 24 months

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.

  14. CREDI motor z-score

    Time frame: 12 months; 24 months

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.

  15. CREDI social-emotional z-score

    Time frame: 12 months; 24 months

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.

  16. Maternal Anxiety

    Time frame: 12 months; 24 months

    Maternal postpartum anziety will be assessed using the the GAD-7 (Generalized Anxiety Disorder-7); a seven-item self-report questionnaire designed to measure the severity of anxiety; categorized as: Minimal Anxiety: score 0-4; Mild Anxiety: score 5-9; Moderate Anxiety: score 10-14; Severe Anxiety: score 15-21

Sponsors and collaborators

Lead sponsor

Swiss Tropical & Public Health Institute

Other

Collaborators

  • Centre Suisse de Recherches Scientifique en Côte d'Ivoire

Registry information

Official study title

Taabo Enhanced Nutrition and Development Through Economic Rewards

Acronym: TENDER

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
May 6, 2026
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.